BAFNAPH.NS · Bafna Pharmaceuticals Limited
India · RS rating 99 · As of 2026-10-14
| Price | 443.50 INR |
|---|---|
| 1-day change | +2.0% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 99 / 99 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 57 / 35 |
| Industry group (rank) | Medical-Generic Drugs (93) |
| EPS growth Q/Q | -97.4% |
| Sales growth Q/Q | -37.1% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $103.9M |